Autres langues Neogen Corporation

Actions

NEOG

US6404911066

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/07/2026			Varia. 5j.	Varia. 1 janv.
12,04 ^USD	+4,42%		+28,09%	+72,25%

30/07	Transcript : Neogen Corporation, Q4 2026 Earnings Call, Jul 30, 2026
30/07	Neogen Corporation publie ses résultats pour le quatrième trimestre et l'exercice clos le 31 mai 2026	CI

Autres langues

30/07	Neogen Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended May 31, 2026
30/07	Neogen Fiscal Q4 Adjusted Earnings Rise, Revenue Declines
30/07	Neogen Corporation Provides Earnings Guidance for the First Quarter and Full Year of 2027
30/07	(NEOG) Neogen Corporation Expects Fiscal Q1 Revenue Range $207M - $209M
30/07	Earnings Flash (NEOG) Neogen Corporation Posts Fiscal Q4 Adjusted EPS $0.09
30/07	Earnings Flash (NEOG) Neogen Corporation Reports Fiscal Q4 Revenue $225.3M
30/07	(NEOG) Neogen Expects Fiscal 2027 Revenue Range $880M - $885M, vs. FactSet Est of $849.1
30/07	Neogen: Fiscal Q4 Earnings Snapshot
30/07	Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
20/07	Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 2026
17/07	Zoetis' acquisition of Neogen Genomics requires Phase 2 review
19/06	Neogen Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight against New World Screwworm
18/06	Neogen Corporation Expands Availability Of FIFRA Section 2(ee) Recommendations for Prozap Insectrin X Concentrate and Prozap Screw Worm and Ear Tick Aerosol
18/06	Neogen Expands Availability of FIFRA Recommendations to Texas, Florida
18/06	Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm
23/04	Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification
09/04	Tranche Update on Neogen Corporation's Equity Buyback Plan announced on October 10, 2018.
09/04	Neogen Corporation Raises Earnings Guidance for the Full Fiscal Year 2026
09/04	Neogen Shares Rise After Fiscal Q3 Results Beat Estimates, Full-Year Sales Outlook Raised
09/04	Neogen(R) Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary
09/04	Neogen Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026
09/04	Stocks Decline Pre-Bell Amid Uncertainty Over US-Iran Truce; Key Inflation Report on Deck
09/04	Neogen : 3Q FY2026 Earnings Call
09/04	Neogen Fiscal Q3 Adjusted Earnings, Revenue Fall; Full-Year Sales Outlook Raised
09/04	(NEOG) Neogen Expects Fiscal 2026 Revenue Range $857M - $860M, vs. FactSet Est of $850.6M